Spirometer Market – By Type (Hand-Held, Table-Top), By Technology (Volume Measurement, Flow Measurement), By Application (Asthma, COPD, Cystic Fibrosis, and Others), By End-User (Hospitals & Clinics, Home Healthcare, and Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030

Report Code: HCR 0570 Report Format: PDF + Excel

Spirometer Market Overview:

Spirometer Market size is estimated to reach US$2.8 billion by 2030, growing at a CAGR of 5.7% during the forecast period 2024-2030. Growing respiratory diseases and Technological advancements are expected to propel the growth of Spirometer Market.

The integration of artificial intelligence (AI) and machine learning into spirometer devices represents a significant trend in the market. With AI-driven algorithms, spirometers can perform advanced data analysis, interpret lung function measurements more accurately, and provide personalized insights for patients. Machine learning techniques allow spirometers to adapt and improve over time, enhancing diagnostic precision and treatment recommendations. Telemedicine has emerged as a prominent trend in healthcare, and the incorporation of spirometry into telehealth platforms is driving innovation in respiratory care. By enabling remote consultations and monitoring, spirometry enhances access to respiratory diagnostics and management, particularly in rural or underserved areas where healthcare resources may be limited. Patients can conveniently perform spirometry tests at home using connected devices, with results transmitted securely to healthcare providers for review. Telemedicine platforms equipped with spirometry capabilities facilitate proactive management of chronic respiratory conditions, allowing for timely interventions and adjustments to treatment plans.

Market Snapshot: 


Spirometer Market - Report Coverage:

The “Spirometer Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Spirometer Market.



By Type

  • Hand-Held
  • Table-Top

By Technology

  • Volume Measurement
  • Flow Measurement

By Application

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Others

By End-User

  • Hospitals & Clinics
  • Home Healthcare
  • Others


By Geography

  • North America (U.S., Canada and Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Netherlands and Rest of Europe),
  • Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific),
  • South America (Brazil, Argentina, Chile, Colombia and Rest of South America)
  • Rest of the World (Middle East and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis:  

● The COVID-19 pandemic has had a mixed impact on the spirometer market. Initially, the market faced challenges due to disruptions in manufacturing, supply chains, and reduced hospital visits for non-emergency procedures. However, the pandemic also highlighted the importance of respiratory health monitoring, leading to increased demand for spirometry devices in diagnosis and management of COVID-19 related respiratory complications.

●    Ukraine's impact on the global spirometer market remains relatively modest. While the country's healthcare sector may have experienced disruptions due to geopolitical tensions and economic challenges, the overall effect on the spirometer market is limited. However, as Ukraine continues to develop its healthcare infrastructure and invest in respiratory care, there may be opportunities for market expansion in the region.

Key Takeaways:

● Table-Top Dominated the Market

According to the Spirometer Market analysis, in the Spirometer market share, Table-Top is analyzed to hold a dominant market share of 66% in 2023. These devices are characterized by their stationary design, typically placed on a stable surface such as a table or desk, making them suitable for use in clinical settings, hospitals, and research laboratories. One of the primary reasons for the dominance of table-top spirometers is their accuracy and reliability in measuring various respiratory parameters, including forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and peak expiratory flow rate (PEF). Table-top spirometers often feature advanced sensors and technology that ensure precise measurements, crucial for diagnosing and monitoring respiratory conditions such as asthma, COPD, and pulmonary fibrosis. Moreover, their larger size allows for the integration of additional features, such as touchscreen displays, built-in printers, and data storage capabilities, enhancing user convenience and workflow efficiency. In clinical settings, table-top spirometers are favored for their ease of use by healthcare professionals, facilitating accurate and timely diagnosis of respiratory disorders. In December 2023, a teacher from the department of physiology at medical college Baroda, India, has bagged patent for developing apprentice spirometer. The development of a new spirometer by an academic institution may lead to increased awareness and adoption of spirometry testing in clinical and research settings.

● Flow Measurement is the fastest growing segment

In the Spirometer Market forecast, Flow Measurement segment is estimated to grow with a CAGR of 5.1% during the forecast period. Advancements in technology have led to the development of highly accurate flow measurement sensors and devices, enabling precise assessment of respiratory function. These technological innovations have improved the reliability and accuracy of flow measurements, making them essential for diagnosing and monitoring various respiratory conditions such as asthma, COPD, and cystic fibrosis. As a result, healthcare professionals increasingly rely on flow measurement spirometers to obtain critical data for patient evaluation and treatment planning. The rising prevalence of respiratory diseases worldwide has fueled the demand for spirometry testing, particularly for assessing airflow obstruction and lung function impairment. Flow measurement spirometers play a crucial role in detecting abnormalities in airflow patterns, which is essential for diagnosing respiratory disorders and monitoring disease progression over time. With the increasing burden of respiratory illnesses, there is a growing need for accurate and reliable flow measurement devices to support early diagnosis and effective management of these conditions. The shift towards personalized medicine and patient-centered care has spurred the demand for flow measurement spirometers that offer customizable features and user-friendly interfaces. Manufacturers are focusing on designing spirometry devices that are easy to use, portable, and suitable for both clinical and home-based settings. These user-centric innovations enhance patient engagement and compliance with spirometry testing, contributing to the overall growth of the flow measurement segment.

● North America to Hold Largest Market Share

According to the Spirometer Market analysis, North America region is estimated to hold the largest market share of 38% in 2023. The region boasts a well-established healthcare infrastructure coupled with high healthcare spending, facilitating widespread adoption of spirometry as a diagnostic tool for respiratory conditions. Additionally, the prevalence of respiratory diseases such as asthma, COPD, and lung cancer in North America is significant, driving the demand for spirometer devices for accurate diagnosis, monitoring, and management of these conditions. Technological advancements and the presence of key market players in North America contribute to the dominance of the region in the spirometer market. The United States, in particular, is home to several leading spirometer manufacturers and innovative healthcare technology companies, fostering a competitive landscape and driving continuous product innovation. Moreover, favorable government initiatives aimed at improving respiratory healthcare, coupled with reimbursement policies for spirometry tests, further fuel market growth in the region. Another crucial factor contributing to North America's dominance is the increasing adoption of telemedicine and remote patient monitoring solutions. Spirometry is increasingly integrated into telehealth platforms, enabling remote consultations and monitoring of respiratory conditions, which is particularly beneficial in rural or underserved areas. These would imply the region as the leader in global spirometer market.

● Growing Respiratory Diseases

Respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, have been on the rise globally due to various factors such as air pollution, smoking, aging populations, and lifestyle changes. Spirometry, a fundamental diagnostic tool in respiratory medicine, plays a crucial role in the early detection, diagnosis, and management of these diseases. By measuring lung function parameters such as forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), spirometry helps healthcare professionals assess respiratory health, monitor disease progression, and tailor treatment plans accordingly. The increasing incidence and prevalence of respiratory diseases have led to a rising demand for spirometry testing across various healthcare settings, including hospitals, clinics, and diagnostic laboratories. As the burden of respiratory illnesses continues to escalate, the spirometer market is poised for sustained growth, driven by the indispensable value of spirometry in enhancing clinical outcomes, optimizing patient care, and improving respiratory health on a global scale.

● Technological Advancements

Traditionally, spirometry tests were conducted in clinical settings using bulky equipment, limiting their utility outside of healthcare facilities. However, the emergence of portable spirometers allows for testing to be conducted in diverse settings, including homes, schools, and workplaces. This portability enables early detection of respiratory conditions, facilitates remote monitoring, and empowers patients to take proactive measures in managing their respiratory health. The integration of wireless connectivity features into spirometer devices has facilitated seamless data transfer and enhanced patient engagement. Wireless connectivity enables spirometers to sync data with smartphones, tablets, or cloud-based platforms, facilitating real-time monitoring and remote consultation. Patients can easily track their lung function trends over time, share data with healthcare providers, and receive timely feedback or interventions. Moreover, healthcare providers benefit from access to comprehensive patient data, enabling informed decision-making and personalized treatment plans. As technology continues to evolve, the spirometer market is poised for further growth and innovation, driving improvements in respiratory health on a global scale.

● Lack of Skilled Workforce Hampers the Market Growth

Spirometry, being a specialized diagnostic procedure, requires trained professionals who can accurately administer the test, interpret the results, and provide appropriate recommendations for patient care. However, the shortage of skilled respiratory therapists, pulmonologists, and healthcare professionals proficient in spirometry techniques poses a challenge to the widespread adoption and utilization of spirometry devices. One of the primary reasons for this shortage is the complexity of spirometry testing and the specialized knowledge required to perform and interpret the tests accurately. Additionally, the rapid advancements in spirometry technology, such as the integration of artificial intelligence and telemedicine capabilities, further necessitate ongoing education and training for healthcare professionals to stay updated with the latest developments. The lack of skilled personnel not only hampers the efficient use of spirometry devices but also impacts patient access to timely and accurate respiratory assessments. In regions where trained professionals are scarce, patients may experience delays in diagnosis, suboptimal management of respiratory conditions, and potentially poorer health outcomes. 


                                                                     For More Details on This Report - Request for Sample

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Spirometer Market. The top 10 companies in this industry are listed below:

  1. Vyaire Medical, Inc.
  2. Hill-Rom Holdings, Inc. (Baxter International Inc.)
  3. Medtronic
  4. Koninklijke Philips N.V.
  5. Schiller AG
  6. Fukuda Sangyo Co., Ltd.
  7. Midmark Corporation
  8. Vitalograph
  9. MGC Diagnostics Corporation (Niterra Co., Ltd.)
  10. ndd Medical Technologies

Scope of Report: 

Report Metric


Base Year Considered


Forecast Period




Market Size in 2030

$2.8 billion

Segments Covered

Type, Technology, Application, End-User


Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Netherlands and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Colombia and Rest of South America), Rest of the World (Middle East and Africa).


Key Market Players

  1. Vyaire Medical, Inc.
  2. Hill-Rom Holdings, Inc. (Baxter International Inc.)
  3. Medtronic
  4. Koninklijke Philips N.V.
  5. Schiller AG
  6. Fukuda Sangyo Co., Ltd.
  7. Midmark Corporation
  8. Vitalograph
  9. MGC Diagnostics Corporation (Niterra Co., Ltd.)
  10. ndd Medical Technologies

For more Lifesciences and Healthcare related reports, please click here

1. Spirometer Market - Overview
    1.1. Definitions and Scope
2. Spirometer Market - Executive Summary
3. Spirometer Market - Comparative Analysis

    3.1. Company Benchmarking - Key Companies
    3.2. Global Financial Analysis - Key Companies
    3.3. Market Share Analysis - Key Companies
    3.4. Patent Analysis
    3.5. Pricing Analysis
4. Spirometer Market - Start-up Companies Scenario
    4.1. Key Start-up Company Analysis by
        4.1.1. Investment
        4.1.2. Revenue
        4.1.3. Venture Capital and Funding Scenario
5. Spirometer Market – Market Entry Scenario Premium
    5.1. Regulatory Framework Overview
    5.2. New Business and Ease of Doing Business Index
    5.3. Case Studies of Successful Ventures
6. Spirometer Market - Forces
    6.1. Market Drivers
    6.2. Market Constraints
    6.3. Market Challenges
    6.4. Porter's Five Force Model
        6.4.1. Bargaining Power of Suppliers
        6.4.2. Bargaining Powers of Customers
        6.4.3. Threat of New Entrants
        6.4.4. Rivalry Among Existing Players
        6.4.5. Threat of Substitutes
7. Spirometer Market – Strategic Analysis
    7.1. Value Chain Analysis
    7.2. Opportunities Analysis
    7.3. Market Life Cycle
8. Spirometer Market – By Type (Market Size – $Million/$Billion) 
    8.1. Hand-Held
    8.2. Table-Top
9. Spirometer Market – By Technology (Market Size – $Million/$Billion) 
    9.1. Volume Measurement
    9.2. Flow Measurement
10. Spirometer Market – By Application (Market Size – $Million/$Billion) 
    10.1. Asthma
    10.2. COPD
    10.3. Cystic Fibrosis
    10.4. Others
11. Spirometer Market – By End-User (Market Size – $Million/$Billion) 
    11.1. Hospitals & Clinics
    11.2. Home Healthcare
    11.3. Others
12. Spirometer Market – By Geography (Market Size – $Million/$Billion) 
    12.1. North America
        12.1.1. Canada
        12.1.2. Mexico
        12.1.3. U.S.
    12.2. South America
        12.2.1. Argentina
        12.2.2. Brazil
        12.2.3. Chile
        12.2.4. Colombia
        12.2.5. Rest of South America
    12.3. Europe
        12.3.1. France
        12.3.2. Germany
        12.3.3. Italy
        12.3.4. Netherlands
        12.3.5. Belgium
        12.3.6. Spain
        12.3.7. UK
        12.3.8. Denmark
        12.3.9. Rest of Europe
    12.4. APAC
        12.4.1. China
        12.4.2. Japan
        12.4.3. India
        12.4.4. South Korea
        12.4.5. Australia and New Zealand
        12.4.6. Indonesia
        12.4.7. Taiwan
        12.4.8. Malaysia
        12.4.9. Rest of APAC
    12.5. RoW
        12.5.1. Saudi Arabia
        12.5.2. South Africa
   Rest of Africa
13. Spirometer Market – Entropy
14. Spirometer Market – Industry/Segment Competition Landscape

    14.1. Market Share Analysis
        14.1.1. Market Share by Region – Key Companies
        14.1.2. Market Share by Country – Key Companies
    14.2. Competition Matrix
    14.3. Best Practices for Companies
15. Spirometer Market – Key Company List by Country Premium
16. Spirometer Market - Company Analysis

    16.1. Vyaire Medical, Inc.
    16.2. Hill-Rom Holdings, Inc. (Baxter International Inc.)
    16.3. Medtronic
    16.4. Koninklijke Philips N.V.
    16.5. Schiller AG
    16.6. Fukuda Sangyo Co., Ltd.
    16.7. Midmark Corporation
    16.8. Vitalograph
    16.9. MGC Diagnostics Corporation (Niterra Co., Ltd.)
    16.10. ndd Medical Technologies
"Financials to the Private Companies would be provided on best-effort basis."

Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.

The Spirometer Market is projected to grow at a CAGR of 5.7% during the forecast period 2024-2030.

Global Spirometer Market size is estimated to be $1.8 billion in 2023 and is projected to reach $2.8 billion by 2030.

The leading players in the Spirometer Market are Vyaire Medical, Inc., Hill-Rom Holdings, Inc. (Baxter International Inc.), Medtronic, Koninklijke Philips N.V., Schiller AG., and Others.

Integration of AI and machine learning and focus on telemedicine penetration are the major trends in spirometer market.

Growing respiratory diseases and Technological advancements are expected to drive the growth of spirometer market. Remote patient monitoring and Growing healthcare infrastructure to create growth opportunities in the market.